Anlotinib versus sunitinib as first-line treatment for metastatic kidney cancer
The results of a recent phase 2 study to evaluate [...]
Safety and efficacy of nivolumab plus TKI combinations in advanced kidney cancer
A phase 1 study has evaluated the safety and efficacy [...]
Safety and tolerability of atezolizumab plus bevacizumab combination for untreated metastatic kidney cancer
The combined safety results of two studies with the atezolizumab [...]
